|
Market Closed -
NYSE
16:00:02 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 164.77 USD | +1.94% |
|
+0.15% | +79.23% |
| 09-03 | UK stocks rise as bond rally lifts risk sentiment | RE |
| 09-03 | AstraZeneca Kept at Buy as Berenberg Notes Upcoming COPD Data Readout | MT |
| Market Cap | 255B 219B 206B 188B 352B 24,107B 354B 2,436B 949B 12,320B 958B 937B 39,677B | P/E 2026 * |
21.2x | P/E 2027 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 274B 236B 222B 203B 378B 25,947B 381B 2,622B 1,021B 13,260B 1,031B 1,008B 42,705B | EV / Sales 2026 * |
4.34x | EV / Sales 2027 * | 3.99x |
| Free-Float |
96.63% | Yield 2026 * |
2.03% | Yield 2027 * | 2.17% |
Last Transcript : AstraZeneca PLC
| 1 day | +1.94% | ||
| Current month | +77.61% | ||
| Current year | +79.23% |
| Current year | 89.04 | 165.74 | |
| 1 year | 72.9 | 165.74 | |
| 3 years | 60.47 | 165.74 | |
| 5 years | 52.65 | 165.74 | |
| 10 years | 25.55 | 165.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 2012-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 2021-07-31 |
Jeffrey Pott
CMP | Compliance Officer | - | 2022-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 1999-04-05 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 2012-09-30 |
Philip Broadley
BRD | Director/Board Member | 65 | 2017-04-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.94% | +0.15% | - | - | 255B | ||
| -0.04% | -1.40% | +57.16% | +108.15% | 1,034B | ||
| +1.17% | +4.76% | +56.42% | +73.50% | 671B | ||
| -0.58% | +0.80% | +22.82% | +75.58% | 460B | ||
| +2.09% | -2.06% | +32.28% | +37.41% | 353B | ||
| 0.00% | +5.36% | +27.40% | +46.97% | 309B | ||
| +1.42% | +0.26% | -0.52% | +13.51% | 255B | ||
| +0.29% | +1.63% | +56.46% | +73.00% | 240B | ||
| -0.03% | +2.13% | -17.30% | -53.65% | 207B | ||
| +1.08% | +1.59% | +33.83% | +97.29% | 188B | ||
| Average | +0.68% | +1.27% | +29.84% | +52.42% | 412.97B | |
| Weighted average by Cap. | +0.45% | +1.04% | +38.60% | +67.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.24B 54.41B 51.06B 46.72B 87.19B 5,978B 87.88B 604B 235B 3,055B 237B 232B 9,839B | 66.84B 57.51B 53.97B 49.38B 92.16B 6,318B 92.89B 638B 249B 3,229B 251B 246B 10,399B |
| Net income | 12.01B 10.34B 9.7B 8.87B 16.56B 1,136B 16.69B 115B 44.68B 580B 45.11B 44.12B 1,869B | 13.69B 11.78B 11.05B 10.11B 18.88B 1,294B 19.03B 131B 50.93B 661B 51.42B 50.29B 2,130B |
| Net Debt | 19.46B 16.75B 15.71B 14.38B 26.83B 1,840B 27.05B 186B 72.39B 940B 73.08B 71.49B 3,028B | 11.79B 10.14B 9.52B 8.71B 16.25B 1,114B 16.38B 113B 43.85B 569B 44.27B 43.3B 1,834B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-03 | US$164.77 | +1.94% | 2,425,271 |
| 26-09-02 | US$161.63 | -0.52% | 3,301,432 |
| 26-09-01 | US$162.47 | +0.21% | 2,598,488 |
| 26-08-31 | US$162.13 | -0.35% | 3,068,214 |
| 26-08-28 | US$162.70 | -1.11% | 2,880,829 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions


















